Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-042305

Director sold 117,000 shares at an average $12.07 ($1,412,414)

From the SEC's structured data for this filing

Trades in this filing

Burrell Terry-Ann · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-12 Sale : show line 1 in the form −24,302 $11.25 $273,400 147,545 D
2023-07-12 Sale : show line 2 in the form −78,071 $12.15 $948,289 69,474 D
2023-07-12 Sale : show line 3 in the form −3,195 $13.18 $42,124 66,279 D
2023-07-12 Sale : show line 4 in the form −3,157 $14.08 $44,457 63,122 D
2023-07-13 Sale : show line 5 in the form −8,275 $12.59 $104,143 54,847 D
Open-market sales · 117,000 sh · avg $12.07 · $1,412,414
Loading xslF345X04/doc4.xml…